Review process begins for WHO listing of Covaxin: Bharat Biotech July 12, 2021 by Indo-Asian News Service
Inching towards WHO’s emergency use approval for Covaxin: Bharat Biotech July 1, 2021 by Press Trust of India
COVID-19 vaccine manufacturers bag huge profits on ‘humanitarian’ cause: Report June 22, 2021 by Sruthi Vibhavari
Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials, say sources June 22, 2021 by Asian News International
DCGI’s expert panel to review Phase III data of Covaxin today June 22, 2021 by Asian News International
PETA urges DCGI to replace calf serum method for vaccine production June 17, 2021 by Indo-Asian News Service
Calf serum used in manufacturing of viral vaccines: Bharat Biotech June 16, 2021 by Indo-Asian News Service
Rs 150 per Covaxin dose not sustainable in long run: Bharat Biotech June 15, 2021 by Press Trust of India
No clarity on COVID-19 vaccine procurement, say private hospitals June 13, 2021 by Press Trust of India
Nine research studies published on Covaxin’s safety in a year: Bharat Biotech June 13, 2021 by Indo-Asian News Service
Nine research studies published on Covaxin’s safety in a year: Bharat Biotech June 12, 2021 by Indo-Asian News Service
IICT scientists who helped in developing Covaxin to pay Rs 1400 per dose June 7, 2021 by Ashutosh Bidla
2nd Made-in-India COVID-19 vaccine coming, deal signed for 30 cr doses June 3, 2021 by Indo-Asian News Service
India to produce 259cr COVID vax doses by year-end: Kishan Reddy May 27, 2021 by Indo-Asian News Service
Took Covaxin jab? Your international travel plans may be hampered May 22, 2021 by Indo-Asian News Service
Covaxin effective against India,UK COVID strains: Bharat Biotech May 17, 2021 by Press Trust of India
